{
  "primary": "Annexin A3",
  "interaction_type": "indirect",
  "upstream_interactor": "TRAF6",
  "mediator_chain": [
    "TRAF6"
  ],
  "depth": 2,
  "support_summary": "ATXN3 influences the NF-κB pathway, which is also regulated by Annexin A3, suggesting a functional connection in inflammatory and cell proliferation processes.",
  "functions": [
    {
      "function": "NF-κB-Mediated Inflammatory Response",
      "arrow": "inhibits",
      "cellular_process": "The activation of the NF-κB pathway is critically dependent on the E3 ligase activity of TRAF6. Annexin A3 is a positive modulator of this pathway, directly binding to both RANK (the receptor) and TRAF6. This interaction promotes TRAF6 stability and enhances the downstream signal transduction to NF-κB, thereby amplifying pro-inflammatory and osteoclastogenic signals.",
      "effect_description": "ATXN3 indirectly counteracts the pro-inflammatory and pro-proliferative functions of Annexin A3. By deubiquitinating and inhibiting the upstream activator TRAF6, ATXN3 dampens the overall flux through the NF-κB signaling cascade. This reduces the signal amplification that would otherwise be promoted by Annexin A3, leading to a reduction in the expression of NF-κB target genes involved in inflammation and cell proliferation.",
      "biological_consequence": [
        "ATXN3 deubiquitinates and inhibits TRAF6 → Overall NF-κB pathway activation is suppressed → The pro-inflammatory signaling enhancement mediated by the Annexin A3-TRAF6 interaction is attenuated → Expression of NF-κB target genes (e.g., inflammatory cytokines) is reduced → Attenuation of inflammatory responses."
      ],
      "specific_effects": [
        "Indirectly reduces the pro-inflammatory activity of Annexin A3 by targeting its upstream activator, TRAF6.",
        "Knockdown of Annexin A3 itself has been shown to alleviate inflammation by inhibiting the NF-κB pathway in models of psoriasis and ischemic injury."
      ],
      "evidence": [
        {
          "paper_title": "Annexin A3 accelerates osteoclast differentiation by promoting the level of RANK and TRAF6",
          "journal": "Biochemical and Biophysical Research Communications",
          "year": 2022,
          "relevant_quote": "Mechanistically, we found that ANXA3 directly bound to RANK and TRAF6 to accelerate osteoclast differentiation by promoting their transcription and limiting degradation. In conclusion, we propose a fundamentally novel RANK-ANXA3-TRAF6 complex to effectively modulate the formation and differentiation of osteoclast to manipulate bone metabolism.",
          "pmid": "37030499"
        },
        {
          "paper_title": "Microglial Annexin A3 Downregulation Alleviates Ischemic Injury by Inhibiting NF-κB/NLRP3-mediated Inflammation",
          "journal": "Neuroscience",
          "year": 2023,
          "relevant_quote": "Our results revealed a positive correlation between ANXA3 expression and activation of the NF-κB/NLRP3 signaling pathway, which was demonstrated by lower levels of ANXA3 along with decreases in p-NF-κB, NLRP3, cleaved caspase-1, N-GSDMD p31 and IL-1β p17 levels.",
          "pmid": "40087252"
        }
      ],
      "pathway": {
        "name": "Inflammatory Response",
        "canonical_name": "Inflammatory Response",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "37030499",
        "40087252"
      ],
      "direct_arrow": "activates",
      "interaction_effect": "inhibition",
      "interaction_direction": "main_to_primary",
      "function_effect": "inhibition",
      "arrow_context": {
        "direct_from": "TRAF6",
        "direct_arrow": "activates",
        "net_from": "ATXN3",
        "net_arrow": "inhibits",
        "mediator_chain": [
          "TRAF6"
        ],
        "is_indirect": true
      },
      "net_arrow": "inhibits",
      "net_effect": "inhibition",
      "direct_effect": "activation"
    }
  ],
  "arrow": "inhibits",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "_chain_inferred": true,
  "_inferred_mediators": [
    "TRAF6"
  ],
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "The activation of the NF-κB pathway is critically dependent on the E3 ligase activity of TRAF6. Annexin A3 is a positive modulator of this pathway, directly binding to both RANK (the receptor) and TRAF6. This interaction promotes TRAF6 stability and enhances the downstream signal transduction to NF-κB, thereby amplifying pro-inflammatory and osteoclastogenic signals.",
  "effect": "ATXN3 indirectly counteracts the pro-inflammatory and pro-proliferative functions of Annexin A3. By deubiquitinating and inhibiting the upstream activator TRAF6, ATXN3 dampens the overall flux through the NF-κB signaling cascade. This reduces the signal amplification that would otherwise be promoted by Annexin A3, leading to a reduction in the expression of NF-κB target genes involved in inflammation and cell proliferation.",
  "summary": "ATXN3 inhibits Annexin A3 to modulate nf-κb-mediated inflammatory response, ultimately affecting attenuation of inflammatory responses.",
  "evidence": [
    {
      "paper_title": "Annexin A3 accelerates osteoclast differentiation by promoting the level of RANK and TRAF6",
      "journal": "Biochemical and Biophysical Research Communications",
      "year": 2022,
      "relevant_quote": "Mechanistically, we found that ANXA3 directly bound to RANK and TRAF6 to accelerate osteoclast differentiation by promoting their transcription and limiting degradation. In conclusion, we propose a fundamentally novel RANK-ANXA3-TRAF6 complex to effectively modulate the formation and differentiation of osteoclast to manipulate bone metabolism."
    },
    {
      "paper_title": "Microglial Annexin A3 Downregulation Alleviates Ischemic Injury by Inhibiting NF-κB/NLRP3-mediated Inflammation",
      "journal": "Neuroscience",
      "year": 2023,
      "relevant_quote": "Our results revealed a positive correlation between ANXA3 expression and activation of the NF-κB/NLRP3 signaling pathway, which was demonstrated by lower levels of ANXA3 along with decreases in p-NF-κB, NLRP3, cleaved caspase-1, N-GSDMD p31 and IL-1β p17 levels."
    }
  ],
  "pathways": [
    {
      "name": "Inflammatory Response",
      "canonical_name": "Inflammatory Response",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "inhibition",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "TRAF6 --inhibits--> Annexin A3:",
  "protein_a": "ATXN3",
  "protein_b": "Annexin A3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-08T02:27:47.400487Z",
  "last_updated": "2025-12-08T02:27:47.400487Z"
}